Most sold healthcare stocks in Q4 2024
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2024, measured as net reductions in reported share positions from Q3 2024 into Q4 2024. Notable reductions at the top of this list include ACADIA HEALTHCARE CO INC (ACHC), STANDARD BIOTOOLS INC (LAB), DOXIMITY INC-CLASS A (DOCS), BUTTERFLY NETWORK INC (BFLY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ACHC | ACADIA HEALTHCARE CO INC | -6,017,498 | -$381.58M | 0 | 0 | 1 | 4 | 1 |
| LAB | STANDARD BIOTOOLS INC | -5,827,076 | -$22.40M | 0 | 0 | 1 | 1 | 2 |
| DOCS | DOXIMITY INC-CLASS A | -4,081,873 | -$124.19M | 3 | 1 | 3 | 0 | 7 |
| BFLY | BUTTERFLY NETWORK INC | -3,744,103 | $2.91M | 1 | 0 | 3 | 1 | 4 |
| PFE | PFIZER INC | -3,651,136 | -$164.86M | 7 | 8 | 14 | 1 | 31 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -3,404,900 | $13.90M | 1 | 2 | 5 | 0 | 9 |
| ME | 23ANDME HOLDING CO -CLASS A | -3,138,861 | -$1.09M | 0 | 0 | 0 | 2 | 0 |
| OPCH | OPTION CARE HEALTH INC | -2,507,593 | -$81.17M | 0 | 1 | 1 | 3 | 2 |
| QSI | QUANTUM-SI INC | -2,490,303 | $14.88M | 1 | 1 | 1 | 0 | 3 |
| NVRO | NEVRO CORP | -2,459,566 | -$14.31M | 0 | 0 | 1 | 1 | 1 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | -2,409,663 | -$33.87M | 0 | 1 | 0 | 1 | 1 |
| CARA | CARA THERAPEUTICS INC | -2,221,974 | -$684.37K | 0 | 0 | 0 | 2 | 0 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -2,116,675 | $23.85M | 0 | 1 | 1 | 0 | 3 |
| FTRE | FORTREA HOLDINGS INC | -1,982,399 | $5.73M | 1 | 1 | 0 | 2 | 2 |
| LBPH | LONGBOARD PHARMACEUTICALS IN | -1,969,141 | -$65.63M | 0 | 0 | 0 | 2 | 0 |
| ZLAB | ZAI LAB LTD-ADR | -1,850,437 | -$44.26M | 0 | 1 | 0 | 1 | 3 |
| SGMO | SANGAMO THERAPEUTICS INC | -1,767,900 | -$1.06M | 0 | 0 | 1 | 0 | 1 |
| CNC | CENTENE CORP | -1,650,968 | -$144.90M | 3 | 3 | 2 | 3 | 9 |
| OSCR | OSCAR HEALTH INC - CLASS A | -1,557,650 | -$126.83M | 2 | 3 | 4 | 0 | 9 |
| BLUE | BLUEBIRD BIO INC | -1,451,674 | -$754.14K | 0 | 0 | 0 | 4 | 0 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | -1,413,300 | -$332.72K | 0 | 0 | 1 | 0 | 3 |
| KZR | KEZAR LIFE SCIENCES INC | -1,297,074 | -$1.00M | 0 | 0 | 0 | 1 | 0 |
| UNH | UNITEDHEALTH GROUP INC | -1,163,039 | -$1.91B | 12 | 21 | 12 | 1 | 51 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -1,026,732 | -$451.81M | 5 | 5 | 5 | 0 | 18 |
| IMVT | IMMUNOVANT INC | -1,021,712 | -$34.69M | 0 | 0 | 2 | 0 | 2 |
| EW | EDWARDS LIFESCIENCES CORP | -1,003,840 | -$53.02M | 3 | 5 | 5 | 0 | 17 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -932,644 | $6.21M | 0 | 0 | 1 | 0 | 2 |
| NRIX | NURIX THERAPEUTICS INC | -932,472 | -$26.51M | 0 | 0 | 1 | 1 | 1 |
| ABT | ABBOTT LABORATORIES | -914,984 | -$122.30M | 6 | 8 | 7 | 0 | 28 |
| VKTX | VIKING THERAPEUTICS INC | -903,717 | -$57.48M | 0 | 1 | 0 | 3 | 1 |
| SNY | SANOFI-ADR | -902,527 | -$769.03M | 2 | 5 | 2 | 1 | 10 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | -886,211 | -$16.17M | 2 | 1 | 2 | 0 | 5 |
| ACCD | ACCOLADE INC | -882,656 | -$5.54M | 1 | 0 | 2 | 0 | 3 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -834,807 | -$174.79M | 4 | 7 | 4 | 1 | 15 |
| HLN | HALEON PLC-ADR | -826,812 | -$197.86M | 1 | 2 | 4 | 0 | 9 |
| CAH | CARDINAL HEALTH INC | -826,527 | -$74.92M | 0 | 4 | 3 | 3 | 8 |
| HRTX | HERON THERAPEUTICS INC | -822,898 | -$2.18M | 0 | 0 | 1 | 1 | 1 |
| MOH | MOLINA HEALTHCARE INC | -795,020 | -$332.23M | 1 | 2 | 5 | 1 | 8 |
| OGN | ORGANON & CO | -740,679 | -$41.84M | 2 | 0 | 5 | 2 | 9 |
| GLYC | GLYCOMIMETICS INC | -739,947 | -$121.76K | 0 | 0 | 1 | 0 | 1 |
| VCYT | VERACYTE INC | -703,850 | $2.94M | 0 | 3 | 1 | 0 | 4 |
| ALHC | ALIGNMENT HEALTHCARE INC | -655,718 | -$11.37M | 0 | 1 | 1 | 0 | 2 |
| BAYRY | BAYER AG-SPONSORED ADR | -653,317 | -$21.71M | 0 | 0 | 1 | 0 | 1 |
| CTLT | CATALENT INC | -652,675 | -$39.53M | 0 | 0 | 0 | 4 | 0 |
| ELAN | ELANCO ANIMAL HEALTH INC | -642,337 | -$224.52M | 1 | 0 | 4 | 0 | 5 |
| NVAX | NOVAVAX INC | -635,890 | -$14.95M | 1 | 1 | 2 | 0 | 6 |
| CHRS | COHERUS BIOSCIENCES INC | -629,537 | -$461.31K | 2 | 0 | 1 | 1 | 3 |
| PSTX | POSEIDA THERAPEUTICS INC | -626,403 | $832.78K | 0 | 0 | 1 | 0 | 2 |
| RPTX | REPARE THERAPEUTICS INC | -615,980 | -$7.12M | 0 | 0 | 2 | 0 | 2 |
| CRBU | CARIBOU BIOSCIENCES INC | -594,200 | -$1.17M | 0 | 0 | 0 | 1 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q4 2024
What are the most sold Healthcare stocks in Q4 2024?
The most sold healthcare stocks in Q4 2024 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2024, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2024?
Among filers in this sector, net reductions were largest in companies such as ACADIA HEALTHCARE CO INC (ACHC), STANDARD BIOTOOLS INC (LAB), DOXIMITY INC-CLASS A (DOCS), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2024).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.